Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 2
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR.
Richer AL, Friel JM, Carson VM, Inge LJ, Whitsett TG. Richer AL, et al. Among authors: carson vm. Pharmgenomics Pers Med. 2015 Feb 20;8:63-79. doi: 10.2147/PGPM.S52845. eCollection 2015. Pharmgenomics Pers Med. 2015. PMID: 25897257 Free PMC article. Review.
WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.
Richer AL, Cala JM, O'Brien K, Carson VM, Inge LJ, Whitsett TG. Richer AL, et al. Among authors: carson vm. Cancer Res. 2017 Sep 1;77(17):4663-4672. doi: 10.1158/0008-5472.CAN-16-3565. Epub 2017 Jun 26. Cancer Res. 2017. PMID: 28652249 Free article.
LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
Whitsett TG, Mittal SK, Eschbacher JM, Carson VM, Smith MA, Bremner RM, Inge LJ. Whitsett TG, et al. Among authors: carson vm. J Thorac Cardiovasc Surg. 2018 Apr;155(4):1891-1899. doi: 10.1016/j.jtcvs.2017.11.067. Epub 2017 Dec 23. J Thorac Cardiovasc Surg. 2018. PMID: 29370903 Free article.